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Abstract
Background: The use of a standard human sequence variant nomenclature is advocated by the Human Genome
Variation Society in order to unambiguously describe genetic variants in databases and literature. There is a clear
need for tools that allow the mining of data about human sequence variants and their functional consequences
from databases and literature. Existing text mining focuses on the recognition of protein variants and their effects.
The recognition of variants at the DNA and RNA levels is essential for dissemination of variant data for diagnostic
purposes. Development of new tools is hampered by the complexity of the current nomenclature, which requires
processing at the character level to recognize the specific syntactic constructs used in variant descriptions.
Results: We approached the gene variant nomenclature as a scientific sublanguage and created two formal
descriptions of the syntax in Extended Backus-Naur Form: one at the DNA-RNA level and one at the protein level.
To ensure compatibility to older versions of the human sequence variant nomenclature, previously recommended
variant description formats have been included. The first grammar versions were designed to help build variant
description handling in the Alamut mutation interpretation software. The DNA and RNA level descriptions were
then updated and used to construct the context-free parser of the Mutalyzer 2 sequence variant nomenclature
checker, which has already been used to check more than one million variant descriptions.
Conclusions: The Extended Backus-Naur Form provided an overview of the full complexity of the syntax of the
sequence variant nomenclature, which remained hidden in the textual format and the division of the
recommendations across the DNA, RNA and protein sections of the Human Genome Variation Society
nomenclature website (http://www.hgvs.org/mutnomen/). This insight into the syntax of the nomenclature could
be used to design detailed and clear rules for software development. The Mutalyzer 2 parser demonstrated that it
facilitated decomposition of complex variant descriptions into their individual parts. The Extended Backus-Naur
Form or parts of it can be used or modified by adding rules, allowing the development of specific sequence
variant text mining tools and other programs, which can generate or handle sequence variant descriptions.
Background
Unambiguous descriptions of genetic variants are impor-
tant to prevent mistakes in the clinical diagnosis of dis-
ease [1]. The Human Genome Variation Society
(HGVS) promotes the use of a standard human
sequence variant nomenclature, which has gradually
evolved as the result of continuous additions and
changes [1-4]. The standard nomenclature has been
designed mainly for use in tables in the literature and in
gene variant databases (locus-specific mutation data-
bases, LSDBs). Due to technological improvements (next
generation sequencing, microarrays), a growing number
of complex variants are now detected at relatively high
resolution, bridging the traditional divide between chro-
mosome analysis in cytogenetic diagnostics and single
gene analysis in DNA diagnostics. This is also reflected
in recently proposed extensions of the standard nomen-
clature [5] and the incorporation of symbols from the
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clature (ISCN 2009) [6].
These extensions increase the complexity of the stan-
dard nomenclature, which is becoming more difficult
for non-experts to understand and use. To assist clini-
cians and researchers, computational tools, such as the
Mutalyzer sequence variant nomenclature checker [7],
have been developed. LSDB curators using LOVD soft-
ware [8] can improve the quality of newly submitted
variant descriptions via the integrated Mutalyzer
module.
Curators contributing the majority of variant data
themselves would welcome automated extraction of var-
iant information at the DNA, RNA and protein levels to
cope with increasing amounts of data in the literature.
The text mining community has started the BioCreative
initiative [9] to assess newly developed methods for the
efficient extraction of data. Several tools have been
developed to extract variant data from the literature
(See [10,11], references therein and other articles in this
special issue). Current efforts have mainly been focuss-
ing on the protein level [10], which reduced the com-
plexity of the search patterns and classifiers needed for
these methods. When users have downloaded literature
relevant for their genes of interest, stand-alone programs
(e.g. MutationFinder [12], mSTRAP [13]) could be used
to extract variant information from selected texts. On-
line databases storing variant data obtained by text
mining tools (e.g. GoGene [14], OSIRIS [15]) could be
queried directly for gene-specific information. This
approach would be more convenient for curators, so we
compared the contents of these databases with those of
the corresponding LSDB for the SDHD gene. This
raised the questions whether the complexity of the
descriptions at the DNA and RNA levels prohibited
their automated extraction by text mining tools and
how this might be solved.
The textual nomenclature recommendations on the
HGVS website are spread over different pages with rela-
tively simple examples, making it difficult to get a com-
plete overview of the complexity of sequence variant
description constructs up to the genotype level. The
HGVS nomenclature can be regarded as a scientific sub-
language [16] using specific typographic and ortho-
graphic conventions to communicate information about
sequence variants. A formal description that aids in
understanding the structure of the nomenclature is cur-
rently lacking. Here we present two formal descriptions
of the syntax in Extended Backus-Naur Form (EBNF)
[17]: one at the DNA-RNA level and one at the protein
level. The DNA-RNA level EBNF has been used to con-
struct the Mutalyzer 2 parser and could form the basis
for other tools. Parts of the EBNF could easily be
extended to accommodate the wider variability of
descriptions encountered in the general literature or
used separately to generate parsers for sequence variant
text mining.
Methods
Standard human sequence variant nomenclature
Version 2.0 of the HGVS standard sequence variant
nomenclature [1-4] was used for the Extended Backus-
Naur Form. The consistency of the nomenclature was
checked, leading to removal of symbol redundancy and
clarification of specific rules after communication with
the HGVS (den Dunnen, manuscript in preparation).
These changes and extensions, which have not yet been
formally approved by the HGVS, have been incorporated
in the formal descriptions presented here. The exten-
sions included the following:
i) The nested change format, which supports descrip-
tions of complex changes such as structural variants [5].
In this format, an A to C substitution at position 158
within an inverted region (position 100 to 200) could be
d e s c r i b e da tt h eg e n o m i cD N Al e v e la sa ni n v e r s i o n
with the substitution as a sub-allele shown between
curly braces, e.g. g.100_200inv{158A>C}. In contrast, the
conventional description would describe it as the dele-
tion-insertion g.100_200delinsAB23456.7 using the Gen-
bank accession number of the sequence of the inverted
region with the substitution.
ii) The symbols / (slash) and // (double slash) used in
the ISCN2009 cytogenetic nomenclature to describe
mosaicism and chimerism, respectively [6]. These sym-
bols would separate the variants found in the different
cell lineages, e.g. g.[158A>C/124C>T] for two different
substitutions found in two different cell lineages of a
individual with germline mosaicism.
iii) The description format used with the new Locus
Reference Genomic (LRG) reference sequences [18].
The fixed annotation of LRG sequences might contain
information about more than one transcript and protein
from the same gene. For descriptions at the RNA and
protein level, these have to be specified using suffices, e.
g. LRG_1t1 and LRG_1p1. New symbols pending HGVS
approval are explained in Table 1.
Development of nomenclature grammar using Extended
Backus-Naur Form
We have used a top-down approach to manually build a
set of syntactic and lexical rules out of the textual
nomenclature recommendations on the HGVS website
[2]. In EBNF, the grammar of a language is defined by a
set of rules like the following: Sentence ® subject verb
complement ‘.’ Rules are conventionally represented
using an arrow separating the head and the body. The
rule above says that a sentence is made of a subject, a
verb and a complement, and is terminated by a ‘.’
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symbol in its head (left-hand side) and a body defining
how terminal and nonterminals y m b o l sl i n kt o g e t h e r .
Sentence and subject are non-terminal symbols, i.e. they
must be defined by a rule. ‘.’ is a terminal symbol and
requires no further definition. In addition to simple
sequences of symbols and characters in the right-hand
part, like in the above rule, a few notational conventions
enable the description of more complex constructs:
￿ A set of literals (characters) is described like this: [A-
Z], which defines the set of latin uppercase letters.
￿ Alternatives are denoted by |, as in: Nucleotide ®
‘A’ | ‘C|‘G’ | ‘T’
￿ Optional constructs are denoted by ?, as in: sentence
® subject verb complement? ‘.’ meaning that a correct
sentence can have a complement, which is optional.
￿ Zero or more occurrences of a construct are denoted
by *. One or more occurrences of a construct are
denoted by
+:
Number ® [0-9]
+ defines numbers as a series of 1 or
more digits.
The EBNF combines terminal symbols (letters, digits,
and other typographic characters) and nonterminal sym-
bols in a recursive set of rules defining a language. Since
variation descriptions at the DNA and RNA levels share
many features, both conceptually and syntactically, we
have unified them into one set of EBNF rules, while a
separate grammar has been derived for the protein level.
Terminal symbols including all characters used in the
HGVS standard sequence variant nomenclature [2] were
depicted using bold print in Additional Files 1 and 2.
For example, the description of a deletion of amino
acids at the protein level was expressed by the following
rule:Del ® AALoc ’del’
The head, Del, was the nonterminal symbol defined by
this rule. The body combined another nonterminal,
AALoc, which is defined by another rule, and the term-
inal ’del’. This rule stated that a protein-level deletion
must be described as the name of an amino acid along
with its position (AALoc), followed by the three letters
‘del’, as in Glyl23del.
Mutalyzer 2 parser construction
The Mutalyzer 1.0.4 Name Checker used regular expres-
sions to parse relatively simple variant descriptions
before checking their correctness [7]. Updating and test-
ing these regular expressions containing many escape
characters due to all symbols used in the nomenclature
was difficult and time consuming, but necessary to
include every nomenclature change. Reliable recognition
of allele and genotype descriptions required designing
regular expressions with more complexity. Therefore,
we decided to simplify parser maintenance using the
approach described below. The new nested change for-
mat introduced an additional description complexity,
which made parsing with regular expressions impossible.
The Pyparsing package [19] is an object-oriented tool
kit for building recursive descent parsers. This type of
parsers has a structure resembling that of the grammar
recognized and supports a recursive set of rules. We
used Pyparsing to transform the EBNF of the HGVS
standard sequence variant nomenclature at the DNA
and RNA levels into the Python code that forms the
parser. Since no parser generation step is involved, the
source code of the parser contained the original descrip-
tion of the nomenclature in a human-readable format.
In this EBNF-like Python code, we have indicated that a
named object must be formed when a particular rule is
Table 1 New symbols and symbol applications in the extended standard human sequence variant nomenclature
a
d Downstream. Position number prefix for coding DNA positions following the end (3’) of the transcript. Example: c.*405+d256G>T
n Position number prefix for non-coding DNA positions. Numbering starts at the first nucleotide of the non-coding transcript. Example: n.46G>T
p Suffix to specify protein isoforms in descriptions using LRG sequences (Locus Reference Genomic) [18]. Example: LRG_1p1
t Suffix to specify transcript variants in descriptions using LRG sequences. Example: LRG_1t1
u Upstream. Position number prefix for coding DNA positions upstream (5’) of the start of the transcript. Example: c.-110-u256G>T
_i Gene symbol suffix to specify protein isoforms in protein variant descriptions using genomic reference sequences. Example: DMD_i2
_v Gene symbol suffix to specify transcript variants in coding DNA variant descriptions using genomic reference sequences. Example: DMD_v2
^ Exclusive or: to combine DNA descriptions, which are derived from protein level descriptions. Example: backtranslation of p.Ser124Arg, where the
Ser-124 codon at c.370_372 is AGC. The variant should be described as c.[370A>C^372C>R] to reflect that arginine can be encoded by six
possible codons, AGR (AGC and AGT) and CGN (CGA, CGC, CGG and CGT), respectively.
/ Allele separator in mosaic cases. Used in ISCN [5]. Example: c.[=/85C>T]
// Allele separator in chimaeric cases. Used in ISCN [5]. Example: c.[=//85C>T]
{ } Curly braces enclose “sub-alleles”, changes within the range of duplications, inversions, gene conversions and insertions. Example: c.24_65inv
{46G>T} (See [4,5] for details)
; Replaces + in SingleAlleleVarSet, MultiAlleleVars and MultiTranscriptVar
(;) Replaces (+) indicating uncertain phase in UnkAlleleVars. In general, parentheses are used to indicate uncertainty.
a See http://www.hgvs.org/mutnomen for a full list of symbols and their use.
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the rule that defines a range is applied and an object
containing two positions must be formed. By selectively
assigning objects to rules, we generated a nested object:
the Mutalyzer 2 parse tree.
Results
Formal description of DNA and RNA variant nomenclature
New symbols have been introduced by recent changes
and extensions of the sequence variant nomenclature
pending formal approval by the HGVS (Table 1). These
symbols and extensions have been included in the DNA
and RNA variant nomenclature grammar represented in
EBNF in Additional File 1. The top level rule, the start-
ing point from which the highest level of complexity
can be processed using the EBNF, is named “Var”.I n
principle, this production rule supports detailed descrip-
tions of complete genotypes, even for individuals with
mosaicism and chimerism. It also refers to “SingleVar”,
the production rule for the simplest variant form, which
handles the format <Reference sequence.version_num-
ber>:<variant_description> (e.g. NM_003002.2:c.274G>T
for the substitution of G at coding sequence oriented
position 274 by T in reference sequence NM_003002.2).
This format contains the minimal information necessary
to reliably generate the variant sequence by hand or
with the Mutalyzer Name Checker [7]. In the literature
and LSDBs, the complete format is rarely used. The
reference sequence should be mentioned in the Materi-
als and Methods section or in the table legends, but is
frequently lacking. In LSDBs, it should be mentioned on
the gene information page. Variants in tables are com-
monly described using the variant_description part. The
Mutalyzer module integrated in LOVD combines the
reference sequence accession number with the variant_-
description part to generate the complete format to
check the description.
For backwards compatibility, rules for several descrip-
tion types used in previous versions have been listed.
These “deviation rules” include “IVS” (Intervening
Sequence) followed by intron number, which has been
used to specify intronic positions. Although often caus-
ing confusion, the description “EX” (exon) followed by
exon number has been included, because of its frequent
use in the Online Mendelian Inheritance in Man
(OMIM) database [20].
Formal description of protein variant nomenclature
Although formal experimental proof of changes at pro-
tein level are mostly lacking, it is common use to report
the predicted effects from the variants detected at the
DNA level. The protein variant grammar represented in
EBNF follows the current version of the standard pro-
tein variant nomenclature (Additional File 2). The top
level rule, the starting point from which the highest
level of complexity can be processed using the EBNF, is
named “ProteinVar”. The production rule for the sim-
plest variant form, “SingleVar”, consists of the reference
sequence and the variant description parts. The EBNF
includes rules for the preferred three-letter amino acid
code as well as the one-letter amino acid code.
Variant description handling in the Alamut software
The grammars were initially created to help implement
the variant parsing and generating capabilities of the
Alamut mutation interpretation software [21]. Alamut is
a decision-support system dedicated to variant interpre-
tation in human genetics. It integrates several molecular
and clinical data sources along with missense and spli-
cing prediction tools inside a graphical gene browser.
Users can enter variants manually, by selecting affected
nucleotides graphically and specifying the type of the
change. The software can also import variants from text
files holding descriptions based on the nomenclature.
Variant parsing in Alamut uses regular expressions
derived from a subset of the DNA-level grammar
defined here, since the software currently handles only
substitutions, insertions, duplications, deletions, and
insertion-deletions. The grammar also serves as an
implementation guide for generating conformant
descriptions out of user-entered variations. The DNA
and protein-level grammars were also used to imple-
ment the text mining tool provided with Alamut. How-
ever, they had to be extended so as to be able to cope
with the numerous lexical variations found in the litera-
ture. For instance, almost 10% of DNA variant descrip-
tions detected in PubMed abstracts use ‘/’, ‘->’,o r‘–>’
instead of ‘>’ for substitutions.
Construction of a context-free nomenclature parser
We successfully incorporated the DNA and RNA variant
nomenclature grammar represented in EBNF into a
recursive descent parser in version 2.0 of the Mutalyzer
software suite [7]. In the Syntax Checker, which pre-
cedes the Mutalyzer 2 nomenclature checker, the parser
is used as an acceptor. If a variant description is not
syntactically correct, this interface will return an error
message, indicating the position in the variant descrip-
tion where the parser halted. This interface can be used
to rapidly check the syntax of many variants (e.g., in a
database) even when a reference sequence is not known
or available. The implementation of the Mutalyzer 2
Syntax Checker can handle separate descriptions in the
standard variant nomenclature. Although not intended
to support full-text analysis, the batch mode of the Syn-
tax Checker could be used to recognize (parts of)
HGVS-compliant descriptions (e.g. NM_003002.2:
c.274G>T, c.274G>T and 274G>T) from a tab delimited
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Descriptions of single variants without nesting including
the reference sequence accession number are recognized
or rejected equally well by both Mutalyzer versions
(results not shown). More complex allele descriptions
with nested changes can only be parsed correctly by
Mutalyzer 2.
Variant data collection and text mining tools
While most LSDBs use specific software [8] for direct
submission of new variants data, most data are still
manually extracted from the literature and entered
manually by LSDB curators. We have investigated if
LSDB curators could use the on-line databases GoGene
[14] and OSIRIS [15], which are filled using text mining
tools, as a source of variant data. For an example of the
efficiency of these tools, we reviewed variant data for
the SDHD gene, for which GoGene (visited Dec 3,
2010) lists a maximum of 30 publications describing a
total of 6 nonsense and 15 missense variants at the pro-
tein level. OSIRIS (visited Dec 3, 2010) contains 1 silent,
3 missense and 39 non-coding variants described at the
DNA level. In contrast, the SDHD LSDB [23] (visited
Dec 3, 2010) contains 253 variants of which 24 have
been submitted directly. The other variants were
extracted manually by the curators from papers obtained
by regular literature searches. The 122 unique variants
include 54 coding region substitutions and 12 intronic
substitutions at the DNA level. At the protein level, 27
missense and 19 nonsense variants are listed.
Discussion
The grammars proposed here have concentrated the lexi-
cal items and syntactic constructs which are scattered
throughout the HGVS nomenclature web pages in one
place. This obviously helps finding potential problems or
ambiguities and adding new constructs. This first effort
to formalize variant nomenclature may eventually lead to
an integrated grammar. The close similarity of the gram-
mar of RNA and DNA variant descriptions already
allowed us to combine these variant nomenclature sub-
languages. A separate grammar for the protein variant
nomenclature sublanguage had to be designed, since pro-
tein variant descriptions are quite different from DNA
and RNA level descriptions. To keep pace with the evolu-
tion of the standard nomenclature, updated versions of
the EBNFs will be regularly available from the Mutalyzer
website [22]. The EBNFs presented here could serve sev-
eral purposes: as a reference for reasoning about the
nomenclature (e.g. identifying constructs which are
allowed by the current nomenclature grammar, but inva-
lid), for further additions (e.g. deviation rules to catch
incorrect descriptions), and for implementation into soft-
ware (e.g. generators of correct variant descriptions,
variant callers for next generation sequencing data, text
mining tools). We consider the implementation of DNA
and RNA level EBNF as a step towards the production of
correct variant descriptions. The sublanguages defined
here are supersets of the actual nomenclature, which are
not restricted by the semantic rules of the standard
human sequence variant nomenclature [2]. The most
important semantic rules, which cannot be described in
EBNF format, have been recapitulated [5]. Therefore,
implementations based on the grammars should restrict
the supersets of otherwise syntactically correct constructs
by semantic checking. Future work will include the addi-
tion of constraints to prevent invalid constructs (e.g.
AA1_AA3 for a protein range in mixed single-letter and
three-letter amino acid code).
Currently, a gap exists between the increasing amounts
of variant data generated with next generation sequencing
and array technologies and the tools available to extract
DNA variant descriptions and their functional conse-
quences at the RNA and protein levels automatically from
textual or tabular formats. Traditionally, the focus of text
mining tools was on the functional consequences of
amino acid substitutions in relation to protein engineering
and biotechnology. Our SDFID data comparison con-
firmed that efforts to extract variant data are currently
limited to the protein level in GoGene and mainly
restricted to entries with dbSNP identifiers in OSIRIS.
Both data sets were smaller than that contained in the cor-
responding gene variant database, which was manually
filled by curators (90 %) and submitters (10 %). One of the
explanations might be that insufficient insight into the
complex structure of the sequence variant nomenclature
and the format of variant descriptions at the DNA and
RNA level was unclear. Another explanation might be that
it is difficult for text mining tools to identify the reference
sequence in the Materials and Methods section or in the
table legends. Both make reliable extraction of variant data
more difficult. Most LSDB curators would prefer on-line
tools which automatically send updates with extracted var-
iants and can be queried on a regular basis, rather than
stand-alone programs, which will have to be separately
installed and may require IT assistance. Therefore, a web-
based implementation of MutationFinder, mSTRAP or
similar tools for generating gene-specific variant informa-
tion may help LSDB curation.
The standard nomenclature provides little guidance on
descriptions in plain text, so multiple formats may be
encountered. In addition, the standard nomenclature was
not always used leading to variant descriptions in which,
for example, the symbol ‘>’ for substitution is replaced by
‘/,’‘ ->’,o r‘–>’. To catch these aberrant variant descrip-
tions, the EBNFs presented here could easily be modified
to develop parsers for text mining tools. This would not
solve the problem of reference sequence identification
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A multi-step approach including pre-processing by a lexi-
cal analyzer [24] to identify the reference sequence acces-
sion number(s) and subsequently connect that to variant
descriptions identified by the Mutalyzer 2 Syntax Checker
might be feasible. The Mutalyzer 2 sequence variant
nomenclature checker could then be used with the format
<Reference sequence.version_number>:<variant_descrip-
tion> to ground identified variants on a specific reference
sequence accession number. Validation of the sequence
variant mining results could then be carried out using the
new LOVD query service [8]. Although the approaches
described here may help to improve the extraction of var-
iant descriptions from literature, authors can make a sig-
nificant contribution by using the standard nomenclature,
and journal editors and reviewers by enforcing its use.
Obviously, listing variant descriptions in the format
<Reference sequence.version_number>:<variant_descrip-
tion> in manuscripts or in associated computer readable
files would solve many of the problems currently experi-
enced by the text mining community.
Conclusions
We have developed formal descriptions of the standard
human sequence variant nomenclature, which can be
easily modified and extended after nomenclature
updates. The EBNFs can be used in combination with
specific software (e.g. Pyparsing) to generate an auto-
matic nomenclature parser. The freely accessible imple-
mentation of such a nomenclature parser, the Syntax
Checker, can be used separately or as part of the Muta-
lyzer 2 Name Checker [22].
The rules in the EBNFs can be extended to accommo-
date the needs of specific disciplines, including those
working with other species. We anticipate that the
grammars presented here will help to close this gap by
supporting the development of tools which also recog-
nize variant descriptions at the level of DNA and RNA.
Additional material
Additional file 1: DNA and RNA variant nomenclature EBNF v.2.0.0.
This file contains the Extended Backus-Naur Form of the human standard
DNA and RNA variant nomenclature v.2.0 used by the parser of
Mutalyzer 2. Format: PDF.
Additional file 2: Protein variant nomenclature EBNF v.2.0.0. This file
contains the Extended Backus-Naur Form of the human standard protein
variant nomenclature v.2.0. Format: PDF.
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